Cabozantinib Looks Promising for Malignant Pheochromocytoma Cabozantinib Looks Promising for Malignant Pheochromocytoma

Tyrosine kinase inhibitor may offer several benefits to patients with malignant pheochromocytomas and paragangliomas, very rare forms of cancer that are difficult to treat.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news